Primary Hypersomnia
Lundbeck Fires First Shot in Bidding War With Alkermes Over Sleep Biotech Avadel
Lundbeck; Alkermes; Avadel; bidding war; sleep biotech; Lumryz; idiopathic hypersomnia; FDA approval; deal; CVR
Actionable Insights Powered by AI
Lundbeck; Alkermes; Avadel; bidding war; sleep biotech; Lumryz; idiopathic hypersomnia; FDA approval; deal; CVR